University at Buffalo (UB)
The symposium aims to highlight genomic and epigenomic technologies, integrative analytical approaches, relevant model organisms, and recent translational findings to identify biologically-significant and clinically translatable disease drivers. Presentations will emphasize novel epigenomic and genomic insights in the context of cancer and other chronic diseases and provide a forum for future collaboration across the region. The symposium will be of interest to basic, translational, and clinical researchers and physicians from academia and industry working at the translational interface. This is a 2-day program from Sept. 23-24.
Karen Madden
Email: karen.madden@roswellpark.org
Phone: 716-845-3851